Patents by Inventor Vivek Lal

Vivek Lal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salt separation and destruction of PFAS utilizing reverse osmosis and salt separation
    Patent number: 11891323
    Abstract: Per- and polyfluoroalkyl substances (PFAS) are destroyed by oxidation in supercritical conditions. PFAS in water is concentrated in a reverse osmosis step and salt from the resulting solution is removed in supercritical conditions prior to destruction of PFAS in supercritical conditions.
    Type: Grant
    Filed: August 9, 2022
    Date of Patent: February 6, 2024
    Assignee: Revive Environmental Technology, LLC
    Inventors: Stephen H. Rosansky, Michael Miller, Patrick Norris, Darwin Argumedo, Douglas Hendry, Ian Haggerty, Keith Brown, Joshua James, Joseph Casciano, Slawomir Winecki, Vivek Lal, Tom McGuinness
  • Inhaled respiratory probiotics for lung diseases of infancy, childhood and adulthood
    Patent number: 11844817
    Abstract: The respiratory microbiomes of neonates and those with bronchopulmonary disease have been characterized. Provided are probiotic compositions, which can include at least one living bacterial strain and at least one killed bacterial strain, that can comprise a combination of Lactobacilli species, 5 that when delivered to the bronchi or lungs of a patient can provide a reduction in the symptoms of a bronchopulmonary disease.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: December 19, 2023
    Assignee: The UAB Research Foundation
    Inventors: Charitharth Vivek Lal, Namasivayam Ambalavanan, Amit Gaggar, Casey Morrow
  • INHALED RESPIRATORY PROBIOTICS FOR LUNG DISEASES OF INFANCY, CHILDHOOD AND ADULTHOOD
    Publication number: 20230372418
    Abstract: The respiratory microbiomes of neonates and those with bronchopulmonary disease have been characterized. Provided are probiotic compositions, which can include at least one living bacterial strain and at least one killed bacterial strain, that can comprise a combination of Lactobacilli species, that when delivered to the bronchi or lungs of a patient can provide a reduction in the symptoms of a bronchopulmonary disease.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 23, 2023
    Inventors: Charitharth Vivek Lal, Namasivayam Ambalavanan, Amit Gaggar, Casey Morrow
  • Salt Separation and Destruction of PFAS Utilizing Reverse Osmosis and Salt Separation
    Publication number: 20230047367
    Abstract: Per- and polyfluoroalkyl substances (PFAS) are destroyed by oxidation in supercritical conditions. PFAS in water is concentrated in a reverse osmosis step and salt from the resulting solution is removed in supercritical conditions prior to destruction of PFAS in supercritical conditions.
    Type: Application
    Filed: August 9, 2022
    Publication date: February 16, 2023
    Inventors: Stephen H. Rosansky, Michael Miller, Patrick Norris, Darwin Argumedo, Douglas Hendry, Ian Haggerty, Keith Brown, Joshua James, Joseph Casciano, Slawomir Winecki, Vivek Lal, Tom McGuinness
  • BACTERIA AND HERBAL EXTRACT NUTRACEUTICAL BLENDS FOR LUNG HEALTH MAINTENANCE
    Publication number: 20220401500
    Abstract: A combination of herbal extracts and a probiotic supplement and formulated as a dietary supplement helps mitigate symptoms of bronchopulmonary disease in conjunction with the anti-inflammatory mechanisms of the probiotics. Provided are embodiments of a probiotic nutraceutical composition that delivers 3 strains of Lactobacillus spp. to the gut lining of human subjects to reduce neutrophilic inflammation as a result of or causative agent of bronchopulmonary disease. In addition to the three Lactobacillus spp. strains, the compositions can include herbal extracts from holy basil, turmeric, and vasaka for respiratory relief.
    Type: Application
    Filed: March 15, 2022
    Publication date: December 22, 2022
    Inventors: Charitharth Vivek Lal, Nancy Wenger
  • Salt separation and destruction of PFAS utilizing reverse osmosis and salt separation
    Patent number: 11407666
    Abstract: Per- and polyfluoroalkyl substances (PFAS) are destroyed by oxidation in supercritical conditions. PFAS in water is concentrated in a reverse osmosis step and salt from the resulting solution is removed in supercritical conditions prior to destruction of PFAS in supercritical conditions.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: August 9, 2022
    Assignee: Battelle Memorial Institute
    Inventors: Stephen H. Rosansky, Michael Miller, Patrick Norris, Darwin Argumedo, Douglas Hendry, Ian Haggerty, Keith Brown, Joshua James, Joseph Casciano, Slawomir Winecki, Vivek Lal, Tom McGuinness
  • Salt Separation and Destruction of PFAS Utilizing Reverse Osmosis and Salt Separation
    Publication number: 20220041483
    Abstract: Per- and polyfluoroalkyl substances (PFAS) are destroyed by oxidation in supercritical conditions. PFAS in water is concentrated in a reverse osmosis step and salt from the resulting solution is removed in supercritical conditions prior to destruction of PFAS in supercritical conditions.
    Type: Application
    Filed: August 6, 2021
    Publication date: February 10, 2022
    Inventors: Stephen H. Rosansky, Michael Miller, Patrick Norris, Darwin Argumedo, Douglas Hendry, Ian Haggerty, Keith Brown, Joshua James, Joe Casciano, Slawomir Winecki, Vivek Lal, Tom McGuinness
  • INHALED RESPIRATORY PROBIOTICS FOR LUNG DISEASES OF INFANCY, CHILDHOOD AND ADULTHOOD
    Publication number: 20210361726
    Abstract: The respiratory microbiomes of neonates and those with bronchopulmonary disease have been characterized. Provided are probiotic compositions, which can include at least one living bacterial strain and at least one killed bacterial strain, that can comprise a combination of Lactobacilli species, 5 that when delivered to the bronchi or lungs of a patient can provide a reduction in the symptoms of a bronchopulmonary disease.
    Type: Application
    Filed: July 23, 2021
    Publication date: November 25, 2021
    Inventors: Charitharth Vivek Lal, Namasivayam Ambalavanan, Amit Gaggar, Casey Morrow
  • Inhaled respiratory probiotics for lung diseases of infancy, childhood and adulthood
    Patent number: 11141443
    Abstract: The respiratory microbiomes of neonates and those with bronchopulmonary disease have been characterized. Provided are probiotic compositions, which can include at least one living bacterial strain and at least one killed bacterial strain, that can comprise a combination of Lactobacilli species, 5 that when delivered to the bronchi or lungs of a patient can provide a reduction in the symptoms of a bronchopulmonary disease.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: October 12, 2021
    Assignee: THE UAB RESEARCH FOUNDATION
    Inventors: Charitharth Vivek Lal, Namasivayam Ambalavanan, Amit Gaggar, Casey Morrow
  • INHALED RESPIRATORY PROBIOTICS FOR LUNG DISEASES OF INFANCY, CHILDHOOD AND ADULTHOOD
    Publication number: 20200054698
    Abstract: The respiratory microbiomes of neonates and those with bronchopulmonary disease have been characterized. Provided are probiotic compositions, which can include at least one living bacterial strain and at least one killed bacterial strain, that can comprise a combination of Lactobacilli species, 5 that when delivered to the bronchi or lungs of a patient can provide a reduction in the symptoms of a bronchopulmonary disease.
    Type: Application
    Filed: April 4, 2018
    Publication date: February 20, 2020
    Inventors: Charitharth Vivek Lal, Namasivayam Ambalavanan, Amit Gaggar, Casey Morrow